pi3k
Entity, reached from Hormuz.
- Evidence
- 42 documents · 15 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 15 Mar 2026, last seen 9 Oct 2026
- Measured
- 14% of mentions say something specific about it; the rest only name it
- As of
- 10 Oct 2026
Where this comes from
- Sci Adv · 2026-09-23 · RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation. (opens the source in a new tab)
- Frontiers Precision Oncology · 2026-09-21 · A case report and diagnostic-therapeutic analysis of de novo bilateral papillary thyroid carcinoma complicated with stage I a diffuse large B-cell lymphoma… (opens the source in a new tab)
- J Ethnopharmacol · 2026-09-18 · Batri-7 Attenuates Established Inflammation-Associated Colorectal Adenoma via PI3K/AKT Inhibition and BAX-Associated Apoptosis. (opens the source in a new tab)
- bioRxiv · 2026-09-15 · Hras G12V induces follicular thyroid cancer with attenuated MAPK activation and increased latency compared to Kras G12D. (opens the source in a new tab)
What is claimed about it
Situations it is named in
Who it moves with
- co-mentioned with immunotherapy (22 documents)seen together
- co-mentioned with colorectal cancer (17 documents)seen together
- co-mentioned with china (17 documents)seen together
- co-mentioned with nuclear (16 documents)seen together
- co-mentioned with kras (15 documents)seen together
- co-mentioned with breast cancer (14 documents)seen together
- co-mentioned with mapk (14 documents)seen together
- co-mentioned with clinical trial (14 documents)seen together
- co-mentioned with tp53 (13 documents)seen together
- co-mentioned with united states (12 documents)seen together